Correction: BMC Endocr Disord 22, 159 (2022)

https://doi.org/10.1186/s12902-022-01068-6

After publication of this article [1], it was brought to our attention that the Fig. 1 is incorrect, the correct Fig. 1 is shown below:

Fig. 1
figure 1

Study population recruited from IPLOSa and linked to data from NorPDe, showing data from 2009. a IPLOS = the Norwegian Information System for the Nursing and Care Sector, b HCS = Home care service, c DM = Diabetes mellitus, pharmacologically treated, d GLD = Glucose lowering drugs, e NorPD = Norwegian Prescription Database. Prescriptions with ATC code A10A (insulins and analogues) is defined as insulin, prescriptions with ATC code A10B (blood glucose lowering drugs, exclusive insulins) is defined as non-insulin glucose lowering drugs (non-insulin GLD) and prescriptions with either ATC code A10A or A10B is defined as glucose lowering drugs (GLD)

The original publication has been corrected.